While TRAIL and its receptors have been implicated in cancer for decades, emerging evidence suggests a role in a multitude of different diseases including viral infection, arthritis, diabetes and cardiovascular disease (Wajant, 2019). This evidence concerns the gene TNFSF10 and cardiovascular disorder.